ORION PHARMA AS

0484 OSLO

Finances

Share Ownership

Return on Equity

71,66 %

Current Ratio

1,69

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	45 856 000	35 898 000	36 741 000	43 231 000
Net Income	7 119 000	1 405 000	1 203 000	1 662 000
Total Assets	22 963 000	14 563 000	15 262 000	18 994 000
Total Equity	9 934 000	4 815 000	5 209 000	6 006 000

Income (NOK)	2022	2021	2020	2019
Revenue	45 856 000	35 898 000	36 741 000	43 231 000
Expenditure	36 779 000	34 075 000	35 151 000	41 113 000
Operating Profit	9 077 000	1 823 000	1 590 000	2 118 000
Financial Income	91 000	8 000	27 000	89 000
Financial Costs	2 000	3 000	7 000	6 000
Financial Balance	89 000	5 000	20 000	83 000
Earnings Before Tax	9 167 000	1 827 000	1 610 000	2 200 000
Tax	2 047 000	422 000	407 000	538 000
Net Income	7 119 000	1 405 000	1 203 000	1 662 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 034 000	1 077 000	1 121 000	1 165 000
Total Current Assets	21 930 000	13 486 000	14 141 000	17 829 000
Total Assets	22 963 000	14 563 000	15 262 000	18 994 000
Total Retained Equity	9 134 000	4 015 000	4 409 000	5 206 000
Total Equity	9 934 000	4 815 000	5 209 000	6 006 000
Total Long-Term Debt	16 000	17 000	16 000	13 000
Total Current Debt	13 014 000	9 731 000	10 037 000	12 974 000
Total Equity and Debt	22 963 000	14 563 000	15 262 000	18 994 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	0	0	0
Other Income	45 856 000	35 898 000	36 741 000	43 231 000
Revenue	45 856 000	35 898 000	36 741 000	43 231 000
Cost of Goods Sold	0	0	0	0
Salary Costs	22 307 000	22 633 000	21 526 000	23 344 000
Depreciation	44 000	44 000	44 000	44 000
Impairment	0	0	0	0
Expenditure	36 779 000	34 075 000	35 151 000	41 113 000
Operating Profit	9 077 000	1 823 000	1 590 000	2 118 000
Financial Income	91 000	8 000	27 000	89 000
Financial Costs	2 000	3 000	7 000	6 000
Financial Balance	89 000	5 000	20 000	83 000
Dividends	2 000 000	1 800 000	2 000 000	3 000 000
Net Income	7 119 000	1 405 000	1 203 000	1 662 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	1 034 000	1 077 000	1 121 000	1 165 000
Total Tangible Assets	1 034 000	1 077 000	1 121 000	1 165 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	1 034 000	1 077 000	1 121 000	1 165 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	8 496 000	9 722 000	8 787 000	12 196 000
Total Current Assets	21 930 000	13 486 000	14 141 000	17 829 000
Total Assets	22 963 000	14 563 000	15 262 000	18 994 000
Total Equity	9 934 000	4 815 000	5 209 000	6 006 000
Short-Term Group Debt	493 000	0	46 000	0
Total Long-Term Debt	16 000	17 000	16 000	13 000
Creditors	665 000	1 255 000	852 000	2 155 000
Unpaid Taxes	2 687 000	2 130 000	1 898 000	2 377 000
Dividends	2 000 000	1 800 000	2 000 000	3 000 000
Other Current Debt	5 120 000	4 125 000	4 837 000	4 910 000
Total Current Debt	13 014 000	9 731 000	10 037 000	12 974 000
Total Equity and Debt	22 963 000	14 563 000	15 262 000	18 994 000

Financial indicators	2022	2021	2020	2019
Return on Equity	71,66 %	29,18 %	23,09 %	27,67 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	19,79 %	5,08 %	4,33 %	4,9 %
Current Ratio	1,69	1,39	1,41	1,37
Quick Ratio	1,69	1,39	1,41	1,37
Equity Ratio	0,43	0,33	0,34	0,32
Gross Profit Margin	100 %	100 %	100 %	100 %